Frequency of Psychiatric Comorbidities in Epilepsy in an Iranian Sample
,
Abstract
Objective: Considering reports on the comorbidities of some psychiatric disorders with epilepsy and in view of some variability in results and lack of needed data in the Iranian population, this study aimed at a further systematic evaluation of various major psychiatric disorders in epileptic patients and compared the results with a control group.Method: In this study, to assess mood, anxiety, and psychotic disorders in patients with epilepsy, 60 patients diagnosed with epilepsy and 60 control individuals matched on age and sex were selected. The case group was conveniently selected from the patients referring to the Iranian Epilepsy Association and the clinic of neurology in Rasoul Akram Hospital, Tehran. A control group whose age and gender were matched with the case group was also selected. Both groups underwent the Structured Clinical Interview for DSM-IV (SCID-I).
Results: Each group included 30 males and 30 females. The mean age was 31.08.97 in patients and 31.28.21 in controls. The lifetime prevalence of major psychiatric disorders including mood, anxiety and psychotic disorders, was 68.3% in individuals with epilepsy and 36.7% in controls (OR=0.28, 95%CI=0.12- 0.57, p<0.05). Among mood disorders, major depressive disorder (MDD) (OR=2.57, 95%CI=1.1 to 5.9, p<0.05) and depressive disorder not otherwise specified (NOS) (p<0.05) prevailed significantly more in patients. Among anxiety disorders, only the frequency of obsessive-compulsive disorder (OCD) was statistically significant (OR=5.2, 95%CI=1.4 to 19, p<0.01).
Conclusions: MDD is the most prevalent comorbidity while OCD and depressive disorder NOS are in the second and third ranks. Therefore, in addition to the main psychiatric disorders, clinicians should pay enough attention to the significance of depressive disorder NOS. Further studies on community based samples, may result in more accurate findings concerning the target population.
Hauser WA, Annegers JF, Kurland LT. Prevalence of epilepsy in Rochester, Minnesota: 1940-1980. Epilepsia 1991; 32: 429-445.
Shackleton DP, Westendorp RG, Kasteleijn- Nolst Trenite DG, de Boer A, Herings RM. Dispensing epilepsy medication: a method of determining the frequency of symptomatic individuals with seizures. J Clin Epidemiol 1997; 50: 1061-1068.
Mohammadi MR, Ghanizadeh A, Davidian H, Mohammadi M, Norouzian M. Prevalence of epilepsy and comorbidity of psychiatric disorders in Iran. Seizure 2006; 15: 476-482.
Swinkels WA, Kuyk J, van Dyck R, Spinhoven P. Psychiatric comorbidity in epilepsy. Epilepsy Behav 2005; 7: 37-50.
Jones JE, Hermann BP, Woodard JL, Barry JJ, Gilliam F, Kanner AM, et al. Screening for major depression in epilepsy with common self-report depression inventories. Epilepsia 2005; 46: 731- 735.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th text revision ed. Washington, DC: American Psychiatric Association; 2000.
Gaitatzis A, Trimble MR, Sander JW. The psychiatric comorbidity of epilepsy. Acta Neurol Scand 2004; 110: 207-220.
Grabowska-Grzyb A, Naganska E, Lechowicz W, Jedrzejcak J, Fiszer U. Description of mood disorder in patients with epilepsy. Pol Merkur Lekarski 2004; 16: 337-339.
Karamad A. [Evaluation of anxiety and depressive disorders in patients with epilepsy aged 10-50 referred to Shahid Beheshti University of Medical Sciences affiliated neurology clinics and the Iranian Epilepsy Association at the second half of 1383]. [MD Thesis]. Tehran. Shahid Beheshti University of Medical Sciences; 2004.
Chalabi A. [Assessment and comparison of patients with epilepsy, patients with renal diseases, and non-patient individuals regarding mental symptoms]. [MD Thesis]. Tehran. Iran University of Medical Sciences; 1997. Spitzer RL, Williams JB, Gibbon M, First MB. The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry 1992; 49: 624-629.
Williams JB, Gibbon M, First MB, Spitzer RL, Davies M, Borus J, et al. The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test- retest reliability. Arch Gen Psychiatry 1992; 49: 630-636.
Zanarini MC, Frankenburg FR. Attainment and maintenance of reliability of axis I and II disorders over the course of a longitudinal study. Compr Psychiatry 2001; 42: 369-374.
Zanarini MC, Skodol AE, Bender D, Dolan R, Sanislow C, Schaefer E, et al. The Collaborative Longitudinal Personality Disorders Study: reliability of axis I and II diagnoses. J Personal Disord 2000; 14: 291-299.
Sharifi V, Assadi SM, Mohammadi MR, Amini H, Kaviani H, Semnani Y, et al. [Reliability and feasibility of the Persian Translation of the Structured Clinical Interview for DSM-IV (SCID)]. Advances in Cognitive Science 2004; 6: 10-22.
Noorbala AA, Bagheri Yazdi SA, Yasamy MT, Mohammad K. Mental health survey of the adult population in Iran. Br J Psychiatry 2004; 184: 70-73.
Mensah SA, Beavis JM, Thapar AK, Kerr M. The presence and clinical implications of depression in a community population of adults with epilepsy. Epilepsy Behav 2006; 8: 213-219.
Prueter C, Norra C. Mood disorders and their treatment in patients with epilepsy. J Neuropsychiatry Clin Neurosci 2005; 17: 20-28.
World Health Organization. The ICD-10 classification of mental and behavioural disorders. Geneva: WHO; 1992.
Attari Moghadam J, Shabani A, Panaghi L. [Frequency of unipolar and bipolar mood disorders in multiple sclerosis]. Advances in Cognitive Science 2005; 6: 57-62.
Kanner AM, Barry JJ. The impact of mood disorders in neurological diseases: should neurologists be concerned? Epilepsy Behav 2003; 4 Suppl 3: 3-13.
Monaco F, Cavanna A, Magli E, Barbagli D, Collimedaglia L, Cantello R, et al. Obsessionality, obsessive-compulsive disorder, and temporal lobe epilepsy. Epilepsy Behav 2005; 7: 491-496.
Aouizerate B, Guehl D, Cuny E, Rougier A, Bioulac B, Tignol J, et al. Pathophysiology of obsessive-compulsive disorder: a necessary link between phenomenology, neuropsychology, imagery and physiology. Prog Neurobiol 2004; 72: 195-221.
Shabani A, Attari Moghadam J, Panaghi L, Seddigh A. Anxiety disorders in multiple sclerosis: significance of obsessive-compulsive disorder comorbidity. JRMS 2007; 12(4), 172- 177.
Shabani A, Nikravesh S, Panaghi L. [Obsessive- compulsive disorder: Is it common in multiple sclerosis?]. Andeesheh va raftar 2006; 3: 209- 215.
Swedo SE, Rapoport JL, Cheslow DL, Leonard HL, Ayoub EM, Hosier DM, et al. High prevalence of obsessive-compulsive symptoms in patients with Sydenham's chorea. Am J Psychiatry 1989; 146: 246-249.
| Files | ||
| Issue | Vol 1 No 4 (2006) | |
| Section | Articles | |
| Keywords | ||
| Anxiety disorders Comorbidity Epilepsy Mood disorders Obsessive-compulsive disorder | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
